Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. S. Friedman
Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma
Clinical Cancer Research
Cancer Research
Oncology
The Combination of Novel Low Molecular Weight Inhibitors of RAF (LBT613) and Target of Rapamycin (RAD001) Decreases Glioma Proliferation and Invasion
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Molecular Profiling of the Âplexinomeâ in Melanoma and Pancreatic Cancer
Human Mutation
Genetics
CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients
JCI insight
Medicine
Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate in Vitro
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
A Targeted Genomic Alteration Analysis Predicts Survival of Melanoma Patients Under BRAF Inhibitors
Oncotarget
Oncology
Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Correction: Molecular Profiling Reveals Low- And High-Grade Forms of Primary Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Molecular Profiling of Pancreatic Cancer Patients—Response
Clinical Cancer Research
Cancer Research
Oncology
Emotional and Behavioural Reactions to Melanoma Genomic Risk Information
British Journal of Dermatology
Dermatology
Medicine
Genomic Profiling of Decreased DNA Damage Response in Human Squamous Carcinoma Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
